Clinical Trial Update: Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating DKN-01 in combination with gemcitabine and cisplatin for biliary tract cancers has completed (completion status reported). The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DKN-01 (dkn-01)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Leap Therapeutics, Inc. | Conditions: Carcinoma of Intrahepatic and Extra-hepatic Biliary System, Carcinoma of Gallbladder | Phase 1 | Status: COMPLETED